• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,610.81 86.55
( 0.12%)
Global Indices
Nasdaq
50,812.84 -74.94
(-0.15%)
Dow Jones
7,426.81 22.07
(0.30%)
Hang Seng
63,697.20 -2,890.92
(-4.34%)
Nikkei 225
10,368.25 0.20
(0.00%)
Forex
USD-INR
95.22 -0.51
(-0.53%)
EUR-INR
109.67 -1.54
(-1.39%)
GBP-INR
126.98 -1.60
(-1.25%)
JPY-INR
0.59 0.00
(-0.77%)

EQUITY - MARKET SCREENER

IRB InvIT Fund
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
540526
INE183W23014
105.4574955
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IRBINVIT
6.81
4797.1
EPS(TTM)
Face Value()
Div & Yield %
8.91
102
9.43
 

u r energy (india) ltd
Bacil Pharma standalone net profit rises 3000.00% in the March 2026 quarter
May 23,2026
Net profit of Bacil Pharma rose 3000.00% to Rs 0.62 crore in the quarter ended March 2026 as against Rs 0.02 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net profit rose 290.00% to Rs 1.56 crore in the year ended March 2026 as against Rs 0.40 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.